Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
SBTX Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
16p
Sell
-1.54%
Downside
Downgraded
06/27/25
SkinBioTherapeutics faces significant financial challenges with ongoing losses and cash burn, which heavily influence its stock score. While technical indicators show bearish trends, recent positive corporate events and strategic moves offer potential future benefits. However, until these translate into improved financial performance, the stock's score remains low.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
16p
Sell
-1.54%
Downside
Downgraded
06/27/25
SkinBioTherapeutics faces significant financial challenges with ongoing losses and cash burn, which heavily influence its stock score. While technical indicators show bearish trends, recent positive corporate events and strategic moves offer potential future benefits. However, until these translate into improved financial performance, the stock's score remains low.
SBTX Analyst Recommendation Trends
Rating
May 25
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
1
4
Sell
0
3
Strong Sell
0
0
total
1
7
Each month's total comprises the sum of three months' worth of ratings.
SBTX Stock Forecast FAQ
What is GB:SBTX’s average 12-month price target, according to analysts?
Based on analyst ratings, SkinBioTherapeutics PLC’s 12-month average price target is 17.00.
What is GB:SBTX’s upside potential, based on the analysts’ average price target?
SkinBioTherapeutics PLC has 4.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SkinBioTherapeutics PLC a Buy, Sell or Hold?
SkinBioTherapeutics PLC has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is SkinBioTherapeutics PLC’s share price target?
The average share price target for SkinBioTherapeutics PLC is 17.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 17.00p ,and the lowest forecast is 17.00p. The average share price target represents 4.62% Increase from the current price of 16.25p.
The highest analyst share price target is 17.00p ,and the lowest forecast is 17.00p. The average share price target represents 4.62% Increase from the current price of 16.25p.
What do analysts say about SkinBioTherapeutics PLC?
SkinBioTherapeutics PLC’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of SkinBioTherapeutics PLC?
To buy shares of GB:SBTX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.